Xylem (NYSE:XYL) Upgraded by Zacks Investment Research to Buy

Xylem (NYSE:XYL) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Sunday, January 21st. The firm presently has a $80.00 target price on the industrial products company’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 11.22% from the stock’s previous close.

According to Zacks, “Xylem’s shares have outperformed the industry in three months’ time. The company believes that robust semiconductor and industrial end-markets’ demand will continue to drive its revenues in the quarters ahead. In addition, greater operational efficacy will likely bolster the company’s near-term bottom-line results. Integration process of the Analytics and Sensus businesses is right on track and is expected to drive its Measurement and Control Solutions segment’s performance in the upcoming quarters. Xylem also intends to fund strategic investment projects and boost shareholders’ return on the back of increased cost savings. Over the last 60 days, Zacks Consensus Estimate for the stock moved north for 2018.”

A number of other equities research analysts have also issued reports on the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $71.00 price target (up previously from $64.00) on shares of Xylem in a research report on Wednesday, October 4th. Canaccord Genuity reaffirmed a “hold” rating and issued a $56.00 price target on shares of Xylem in a research report on Friday, October 6th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $63.00 price target on shares of Xylem in a research report on Friday, October 13th. Oppenheimer increased their price target on Xylem from $66.00 to $75.00 and gave the company an “outperform” rating in a research report on Wednesday, November 1st. Finally, Boenning Scattergood reaffirmed a “buy” rating on shares of Xylem in a research report on Friday, December 15th. Five research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $70.08.

Xylem (XYL) traded up $1.11 on Friday, reaching $71.93. The company had a trading volume of 1,040,463 shares, compared to its average volume of 1,123,268. Xylem has a 1 year low of $46.95 and a 1 year high of $76.81. The company has a current ratio of 1.88, a quick ratio of 1.41 and a debt-to-equity ratio of 0.87. The firm has a market cap of $12,719.27, a price-to-earnings ratio of 39.28, a price-to-earnings-growth ratio of 1.35 and a beta of 1.20.

Xylem (NYSE:XYL) last posted its earnings results on Thursday, February 1st. The industrial products company reported $0.76 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.76. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. Xylem’s revenue was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. research analysts anticipate that Xylem will post 2.91 earnings per share for the current year.

In related news, insider Tomas Brannemo sold 2,260 shares of the firm’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $67.75, for a total transaction of $153,115.00. Following the transaction, the insider now owns 10,975 shares in the company, valued at approximately $743,556.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Steven R. Loranger sold 47,712 shares of the firm’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $68.10, for a total value of $3,249,187.20. Following the transaction, the director now owns 68,843 shares in the company, valued at approximately $4,688,208.30. The disclosure for this sale can be found here. Insiders have sold a total of 75,455 shares of company stock worth $5,166,873 in the last three months. Corporate insiders own 0.75% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in XYL. Federated Investors Inc. PA grew its stake in Xylem by 5.8% during the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after buying an additional 181 shares during the last quarter. Wells Fargo & Company MN grew its stake in Xylem by 8.4% during the 2nd quarter. Wells Fargo & Company MN now owns 182,960 shares of the industrial products company’s stock worth $10,141,000 after buying an additional 14,203 shares during the last quarter. TIAA CREF Investment Management LLC grew its stake in Xylem by 3.0% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 395,004 shares of the industrial products company’s stock worth $21,895,000 after buying an additional 11,336 shares during the last quarter. Thrivent Financial For Lutherans grew its stake in Xylem by 63.0% during the 2nd quarter. Thrivent Financial For Lutherans now owns 118,249 shares of the industrial products company’s stock worth $6,554,000 after buying an additional 45,689 shares during the last quarter. Finally, New York State Common Retirement Fund grew its stake in Xylem by 0.8% during the 2nd quarter. New York State Common Retirement Fund now owns 560,722 shares of the industrial products company’s stock worth $31,081,000 after buying an additional 4,499 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Xylem (NYSE:XYL) Upgraded by Zacks Investment Research to Buy” was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/02/12/xylem-xyl-upgraded-by-zacks-investment-research-to-buy-updated-updated-updated.html.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply